Skip to main content
. 2014 May 28;9(5):e97328. doi: 10.1371/journal.pone.0097328

Table 6. Impact of platelet transfusion and patient factors on the mortality at day 7.

Model 1 Model 2 Model 3 Model 4 Model 5
Effect of APA on survival Effect of FFP and PLT on survival Effect of FFP on survival Effect of PLT on survival Effect of broad APA on survival
Univariate Multivariate Multivariate Multivariate Multivariate Multivariate
Variables B OR P 95% CI B OR P 95% CI B OR P 95% CI B OR P 95% CI B OR P 95% CI B OR P 95% CI
Age 0.01 1.01 0.19 0.99-1.03 0.03 1.03 0.1 1.00-1.06 0.02 1.02 0.22 0.99-1.05 0.02 1.02 0.2 0.98-1.05 0.03 1.03 0.1 1.00-1.06 0.03 1.03 0.04 1.00-1.06
Sex 0.03 1.01 0.67 0.72-1.69
Elapsed time -0.01 0.98 0.29 0.96-1.01
Glasgow coma scale -0.55 0.57 <0.0001 0.50-0.64 -0.44 0.64 <0.0001 0.57-0.74 -0.43 0.66 <0.0001 0.57-0.75 -0.43 0.65 <0.0001 0.57-0.74 -0.43 0.65 <0.0001 0.57-0.74 -0.44 0.65 <0.0001 0.57-0.73
Chronic Renal Failure 0.47 1.61 0.14 0.85-3.02
Liver cirrhosis 1.22 3.3 0.02 1.30-8.56 0.88 2.4 0.24 0.55-10.5 0.92 2.5 0.25 0.52-12.0 0.9 2.47 0.25 0.53-11.4 0.9 2.47 0.24 0.54-11.2 0.82 2.27 0.28 0.52-9.86
Hypertension -0.13 0.88 0.72 0.42-1.82 -0.71 0.43 0.28 0.14-1.77 -0.59 0.56 0.39 0.15-2.14 -0.65 0.52 0.34 0.14-1.99 -0.56 0.4 0.57 0.15-2.11 -0.65 0.52 0.31 0.15-1.83
CHD 0.35 1.41 0.48 0.54-3.67
Diabetes mellitus -0.58 0.56 0.12 0.27-1.15 -0.56 0.57 0.30 0.20-1.66 -0.6 0.55 0.29 0.18-1.66 -0.6 0.55 0.29 0.18-1.67 -0.63 0.53 0.18 0.12-1.57 -0.48 0.62 0.37 0.22-1.76
Atrial fibrillation -1.05 0.34 0.33 0.04-2.95
TIA 0.47 1.60 0.32 0.63-4.05
Anti-platelet agents 0.17 1.18 0.61 0.62-2.24 1.63 5.12 0.006 1.59-16.5 1.91 6.78 0.004 1.84-24.9 1.78 5.91 0.006 1.68-20.9 1.86 6.48 0.003 1.88-22.3
Warfarin 0.35 1.42 0.37 0.66-3.07 -0.28 0.76 0.7 0.18-3.1 0.37 1.44 0.67 0.27-7.68 0.25 1.28 0.77 0.25-6.51 0.03 1.03 0.97 0.23-4.71 -0.19 0.83 0.8 0.2-3.4
Broad APA 0.15 1.16 0.57 0.70-1.92 0.99 2.7 0.06 0.95-7.63
Location
subcortical -0.24 0.79 0.43 0.44-1.43
supratentorial -0.33 0.72 0.14 0.47-1.11
infratentorial 0.73 2.01 0.002 1.31-3.28 0.23 1.26 0.53 0.61-2.6 0.36 1.42 0.36 0.67-3.03 0.37 1.28 0.76 0.68-3.07 0.23 1.25 0.55 0.60-2.61 0.24 1.27 0.52 0.62-2.60
Volume of ICH 0.003 1.01 <0.0001 1.006-1.01 0.003 1.003 0.06 1.00-1.01 0.004 1.004 0.04 1-1.01 0.004 1.002 0.04 1.00-1.01 0.003 1.003 0.046 1-1.007 0.003 1.003 0.06 1-1.006
Disease progression 3.96 52.5 <0.0001 20.6-133.9 3.46 32 <0.0001 10.24-99.7 3.5 33.1 <0.0001 10.1-108.1 3.47 32.2 <0.0001 10.1-102.6 3.51 33.4 <0.0001 10.4-107.7 3.28 26.6 <0.0001 9.18-77.2
Operation 0.63 1.89 <0.0001 1.39-2.54
IVH 0.20 1.23 0.40 0.76-1.97
Platelet count -0.04 0.96 0.011 0.93-0.99 -0.006 0.98 0.47 0.93-1.03 -0.04 0.97 0.21 0.91-1.02 -0.03 0.97 0.22 0.92-1.02 -0.03 0.97 0.32 0.92-1.03 -0.02 0.98 0.32 0.93-1.03
PT -0.02 0.99 0.001 0.98-0.99
aPTT 0.04 1.02 0.11 0.99-1.05
Fibrinogen -0.001 1.00 0.52 0.99-1.00 0.001 1 0.8 0.93-1.03 0.001 1 0.98 1.00-1.01 0.0001 1 0.98 0.997-1.003 0.0001 1 0.91 0.997-1.003 0.001 1.001 0.72 0.998-1.003
Platelet transfusion -0.98 4.02 0.07 0.90-18.1 -1.49 0.23 0.26 0.02-3.02 -2.62 0.03 0.07 0.01-0.75
FFP transfusion 1.44 4.20 0.009 1.44-12.3 2.23 0.04 0.008 1.81-48.0 2.59 13.3 0.001 2.85-62.6

CHD: coronary heart disease; PH of TIA: past history of transient ischemic attack; APA: anti-platelet agents; IVH: intraventricular hemorrhage.

ICH: intracerebral hemorrhage; PT: prothrombin time; aPTT: activated partial thromboplastin time; OR: odds ratio; CI: confidence interval.